Still Possible to Divert from Disastrous Climate Path to Sustainable, Healthy Planet, says UNEP 09/12/2025 Chetan Bhattacharji A baby born today will turn 75 in 2100, and the world she will inherit – if governments don’t act in the next five years – could be 3.9°C hotter, economically shattered, and ravaged by pollution. But there is still a choice, a new United Nations Environment Programme (UNEP) report shows. A sustainable, transformative path […] Continue reading -> US-Africa Bilateral Deals Steam Ahead as WHO Struggles to Finalise Global Pathogen Agreement 08/12/2025 Kerry Cullinan As World Health Organization (WHO) member states decided to hold a new round of talks in January on establishing a global pathogen access and benefit sharing (PABS) system, the US signed its first bilateral health agreements, which include pathogen-sharing arrangements, with Kenya and Rwanda late last week. The WHO talks on PABS, the last remaining […] Continue reading -> Over Half the World’s Population Lacked Access to Basic Health Services in 2023 06/12/2025 Elaine Ruth Fletcher Some 4.6 billion people, or more than half the world’s population, still lacked access to a basic package of essential health services in 2023, a new World Health Organization-World Bank report notes. And around 2.1 billion people faced financial hardship in getting vital health services. And at current rates, the world will fall far short […] Continue reading -> CDC Committee Delays Hepatitis B Vaccine for Newborns in Critical Guidelines Shift 05/12/2025 Sophia Samantaroy A United States vaccine advisory panel, recently reformed to include known vaccine skeptics, voted to eliminate a three-decade-long recommendation that all newborns in the US receive a vaccine to protect against hepatitis B (Hep B) at birth – a change that was denounced immediately by medical groups like the American Academy of Pediatrics and the […] Continue reading -> Gavi Cuts Staff and Support to WHO and UNICEF – Gives More Freedom to Countries to Decide Vaccine Priorities 05/12/2025 Elaine Ruth Fletcher Gavi, the Vaccine Alliance has pared down its staff in its Geneva headquarters, Washington DC and New York by 33% – from 643 to 440 people, the agency confirmed today, following a June replenishment drive that fell about $2 billion short of a $11.9 billion fundraising goal for 2026-2030. Beginning in 2026, the agency will […] Continue reading -> Collaboration Across Africa is Key to Increasing Clinical Trials 05/12/2025 Sophia Samantaroy In Kenya, toxicologists and epidemiologists face a difficult choice: to pursue better-paid work to support their families, or volunteer as reviewers for vaccine clinical trials, often without the compensation needed to cover even their children’s school fees. Their dilemma underscores a broader challenge in Africa’s clinical research ecosystem. Slow, duplicative approval processes and limited regulatory […] Continue reading -> US City Sues Ultra-Processed Food Companies, Seeking ‘Restitution’ for Health Costs 05/12/2025 Kerry Cullinan The City of San Francisco has filed a historic lawsuit against 10 ultra-processed food (UPF) manufacturers, seeking “restitution and civil penalties” to help local governments to “offset astronomical health care costs associated with UPF consumption”. The 10 companies are Kraft Heinz Company, Mondelez International, Post Holdings, The Coca-Cola Company, PepsiCo, General Mills, Nestle USA, Kellogg, […] Continue reading -> Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> Paper Exonerating Herbicide is Retracted; Bayer Gets Trump’s Help to Avoid Claims from Cancer Patients 04/12/2025 Kerry Cullinan A scientific paper written 25 years ago, claiming that the herbicide glyphosate posed little risk to people, has finally been withdrawn after it was found that the authors relied solely on Monsanto studies and did not acknowledge that Monsanto staff had assisted in writing the paper. Monsanto makes the glyphosate-based Roundup, used as a weedkiller […] Continue reading -> WHO Issues First-Ever Guidelines for GLP-1 Drugs – Including Obesity 04/12/2025 Sophia Samantaroy First-ever WHO guidelines recommending the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults has been issued by the World Health Organization – in what the global health agency said is a “conditional” sign of approval for the cutting edge medications that have become widely popular. The new WHO recommendations go […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US-Africa Bilateral Deals Steam Ahead as WHO Struggles to Finalise Global Pathogen Agreement 08/12/2025 Kerry Cullinan As World Health Organization (WHO) member states decided to hold a new round of talks in January on establishing a global pathogen access and benefit sharing (PABS) system, the US signed its first bilateral health agreements, which include pathogen-sharing arrangements, with Kenya and Rwanda late last week. The WHO talks on PABS, the last remaining […] Continue reading -> Over Half the World’s Population Lacked Access to Basic Health Services in 2023 06/12/2025 Elaine Ruth Fletcher Some 4.6 billion people, or more than half the world’s population, still lacked access to a basic package of essential health services in 2023, a new World Health Organization-World Bank report notes. And around 2.1 billion people faced financial hardship in getting vital health services. And at current rates, the world will fall far short […] Continue reading -> CDC Committee Delays Hepatitis B Vaccine for Newborns in Critical Guidelines Shift 05/12/2025 Sophia Samantaroy A United States vaccine advisory panel, recently reformed to include known vaccine skeptics, voted to eliminate a three-decade-long recommendation that all newborns in the US receive a vaccine to protect against hepatitis B (Hep B) at birth – a change that was denounced immediately by medical groups like the American Academy of Pediatrics and the […] Continue reading -> Gavi Cuts Staff and Support to WHO and UNICEF – Gives More Freedom to Countries to Decide Vaccine Priorities 05/12/2025 Elaine Ruth Fletcher Gavi, the Vaccine Alliance has pared down its staff in its Geneva headquarters, Washington DC and New York by 33% – from 643 to 440 people, the agency confirmed today, following a June replenishment drive that fell about $2 billion short of a $11.9 billion fundraising goal for 2026-2030. Beginning in 2026, the agency will […] Continue reading -> Collaboration Across Africa is Key to Increasing Clinical Trials 05/12/2025 Sophia Samantaroy In Kenya, toxicologists and epidemiologists face a difficult choice: to pursue better-paid work to support their families, or volunteer as reviewers for vaccine clinical trials, often without the compensation needed to cover even their children’s school fees. Their dilemma underscores a broader challenge in Africa’s clinical research ecosystem. Slow, duplicative approval processes and limited regulatory […] Continue reading -> US City Sues Ultra-Processed Food Companies, Seeking ‘Restitution’ for Health Costs 05/12/2025 Kerry Cullinan The City of San Francisco has filed a historic lawsuit against 10 ultra-processed food (UPF) manufacturers, seeking “restitution and civil penalties” to help local governments to “offset astronomical health care costs associated with UPF consumption”. The 10 companies are Kraft Heinz Company, Mondelez International, Post Holdings, The Coca-Cola Company, PepsiCo, General Mills, Nestle USA, Kellogg, […] Continue reading -> Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> Paper Exonerating Herbicide is Retracted; Bayer Gets Trump’s Help to Avoid Claims from Cancer Patients 04/12/2025 Kerry Cullinan A scientific paper written 25 years ago, claiming that the herbicide glyphosate posed little risk to people, has finally been withdrawn after it was found that the authors relied solely on Monsanto studies and did not acknowledge that Monsanto staff had assisted in writing the paper. Monsanto makes the glyphosate-based Roundup, used as a weedkiller […] Continue reading -> WHO Issues First-Ever Guidelines for GLP-1 Drugs – Including Obesity 04/12/2025 Sophia Samantaroy First-ever WHO guidelines recommending the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults has been issued by the World Health Organization – in what the global health agency said is a “conditional” sign of approval for the cutting edge medications that have become widely popular. The new WHO recommendations go […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Over Half the World’s Population Lacked Access to Basic Health Services in 2023 06/12/2025 Elaine Ruth Fletcher Some 4.6 billion people, or more than half the world’s population, still lacked access to a basic package of essential health services in 2023, a new World Health Organization-World Bank report notes. And around 2.1 billion people faced financial hardship in getting vital health services. And at current rates, the world will fall far short […] Continue reading -> CDC Committee Delays Hepatitis B Vaccine for Newborns in Critical Guidelines Shift 05/12/2025 Sophia Samantaroy A United States vaccine advisory panel, recently reformed to include known vaccine skeptics, voted to eliminate a three-decade-long recommendation that all newborns in the US receive a vaccine to protect against hepatitis B (Hep B) at birth – a change that was denounced immediately by medical groups like the American Academy of Pediatrics and the […] Continue reading -> Gavi Cuts Staff and Support to WHO and UNICEF – Gives More Freedom to Countries to Decide Vaccine Priorities 05/12/2025 Elaine Ruth Fletcher Gavi, the Vaccine Alliance has pared down its staff in its Geneva headquarters, Washington DC and New York by 33% – from 643 to 440 people, the agency confirmed today, following a June replenishment drive that fell about $2 billion short of a $11.9 billion fundraising goal for 2026-2030. Beginning in 2026, the agency will […] Continue reading -> Collaboration Across Africa is Key to Increasing Clinical Trials 05/12/2025 Sophia Samantaroy In Kenya, toxicologists and epidemiologists face a difficult choice: to pursue better-paid work to support their families, or volunteer as reviewers for vaccine clinical trials, often without the compensation needed to cover even their children’s school fees. Their dilemma underscores a broader challenge in Africa’s clinical research ecosystem. Slow, duplicative approval processes and limited regulatory […] Continue reading -> US City Sues Ultra-Processed Food Companies, Seeking ‘Restitution’ for Health Costs 05/12/2025 Kerry Cullinan The City of San Francisco has filed a historic lawsuit against 10 ultra-processed food (UPF) manufacturers, seeking “restitution and civil penalties” to help local governments to “offset astronomical health care costs associated with UPF consumption”. The 10 companies are Kraft Heinz Company, Mondelez International, Post Holdings, The Coca-Cola Company, PepsiCo, General Mills, Nestle USA, Kellogg, […] Continue reading -> Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> Paper Exonerating Herbicide is Retracted; Bayer Gets Trump’s Help to Avoid Claims from Cancer Patients 04/12/2025 Kerry Cullinan A scientific paper written 25 years ago, claiming that the herbicide glyphosate posed little risk to people, has finally been withdrawn after it was found that the authors relied solely on Monsanto studies and did not acknowledge that Monsanto staff had assisted in writing the paper. Monsanto makes the glyphosate-based Roundup, used as a weedkiller […] Continue reading -> WHO Issues First-Ever Guidelines for GLP-1 Drugs – Including Obesity 04/12/2025 Sophia Samantaroy First-ever WHO guidelines recommending the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults has been issued by the World Health Organization – in what the global health agency said is a “conditional” sign of approval for the cutting edge medications that have become widely popular. The new WHO recommendations go […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
CDC Committee Delays Hepatitis B Vaccine for Newborns in Critical Guidelines Shift 05/12/2025 Sophia Samantaroy A United States vaccine advisory panel, recently reformed to include known vaccine skeptics, voted to eliminate a three-decade-long recommendation that all newborns in the US receive a vaccine to protect against hepatitis B (Hep B) at birth – a change that was denounced immediately by medical groups like the American Academy of Pediatrics and the […] Continue reading -> Gavi Cuts Staff and Support to WHO and UNICEF – Gives More Freedom to Countries to Decide Vaccine Priorities 05/12/2025 Elaine Ruth Fletcher Gavi, the Vaccine Alliance has pared down its staff in its Geneva headquarters, Washington DC and New York by 33% – from 643 to 440 people, the agency confirmed today, following a June replenishment drive that fell about $2 billion short of a $11.9 billion fundraising goal for 2026-2030. Beginning in 2026, the agency will […] Continue reading -> Collaboration Across Africa is Key to Increasing Clinical Trials 05/12/2025 Sophia Samantaroy In Kenya, toxicologists and epidemiologists face a difficult choice: to pursue better-paid work to support their families, or volunteer as reviewers for vaccine clinical trials, often without the compensation needed to cover even their children’s school fees. Their dilemma underscores a broader challenge in Africa’s clinical research ecosystem. Slow, duplicative approval processes and limited regulatory […] Continue reading -> US City Sues Ultra-Processed Food Companies, Seeking ‘Restitution’ for Health Costs 05/12/2025 Kerry Cullinan The City of San Francisco has filed a historic lawsuit against 10 ultra-processed food (UPF) manufacturers, seeking “restitution and civil penalties” to help local governments to “offset astronomical health care costs associated with UPF consumption”. The 10 companies are Kraft Heinz Company, Mondelez International, Post Holdings, The Coca-Cola Company, PepsiCo, General Mills, Nestle USA, Kellogg, […] Continue reading -> Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> Paper Exonerating Herbicide is Retracted; Bayer Gets Trump’s Help to Avoid Claims from Cancer Patients 04/12/2025 Kerry Cullinan A scientific paper written 25 years ago, claiming that the herbicide glyphosate posed little risk to people, has finally been withdrawn after it was found that the authors relied solely on Monsanto studies and did not acknowledge that Monsanto staff had assisted in writing the paper. Monsanto makes the glyphosate-based Roundup, used as a weedkiller […] Continue reading -> WHO Issues First-Ever Guidelines for GLP-1 Drugs – Including Obesity 04/12/2025 Sophia Samantaroy First-ever WHO guidelines recommending the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults has been issued by the World Health Organization – in what the global health agency said is a “conditional” sign of approval for the cutting edge medications that have become widely popular. The new WHO recommendations go […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Gavi Cuts Staff and Support to WHO and UNICEF – Gives More Freedom to Countries to Decide Vaccine Priorities 05/12/2025 Elaine Ruth Fletcher Gavi, the Vaccine Alliance has pared down its staff in its Geneva headquarters, Washington DC and New York by 33% – from 643 to 440 people, the agency confirmed today, following a June replenishment drive that fell about $2 billion short of a $11.9 billion fundraising goal for 2026-2030. Beginning in 2026, the agency will […] Continue reading -> Collaboration Across Africa is Key to Increasing Clinical Trials 05/12/2025 Sophia Samantaroy In Kenya, toxicologists and epidemiologists face a difficult choice: to pursue better-paid work to support their families, or volunteer as reviewers for vaccine clinical trials, often without the compensation needed to cover even their children’s school fees. Their dilemma underscores a broader challenge in Africa’s clinical research ecosystem. Slow, duplicative approval processes and limited regulatory […] Continue reading -> US City Sues Ultra-Processed Food Companies, Seeking ‘Restitution’ for Health Costs 05/12/2025 Kerry Cullinan The City of San Francisco has filed a historic lawsuit against 10 ultra-processed food (UPF) manufacturers, seeking “restitution and civil penalties” to help local governments to “offset astronomical health care costs associated with UPF consumption”. The 10 companies are Kraft Heinz Company, Mondelez International, Post Holdings, The Coca-Cola Company, PepsiCo, General Mills, Nestle USA, Kellogg, […] Continue reading -> Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> Paper Exonerating Herbicide is Retracted; Bayer Gets Trump’s Help to Avoid Claims from Cancer Patients 04/12/2025 Kerry Cullinan A scientific paper written 25 years ago, claiming that the herbicide glyphosate posed little risk to people, has finally been withdrawn after it was found that the authors relied solely on Monsanto studies and did not acknowledge that Monsanto staff had assisted in writing the paper. Monsanto makes the glyphosate-based Roundup, used as a weedkiller […] Continue reading -> WHO Issues First-Ever Guidelines for GLP-1 Drugs – Including Obesity 04/12/2025 Sophia Samantaroy First-ever WHO guidelines recommending the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults has been issued by the World Health Organization – in what the global health agency said is a “conditional” sign of approval for the cutting edge medications that have become widely popular. The new WHO recommendations go […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Collaboration Across Africa is Key to Increasing Clinical Trials 05/12/2025 Sophia Samantaroy In Kenya, toxicologists and epidemiologists face a difficult choice: to pursue better-paid work to support their families, or volunteer as reviewers for vaccine clinical trials, often without the compensation needed to cover even their children’s school fees. Their dilemma underscores a broader challenge in Africa’s clinical research ecosystem. Slow, duplicative approval processes and limited regulatory […] Continue reading -> US City Sues Ultra-Processed Food Companies, Seeking ‘Restitution’ for Health Costs 05/12/2025 Kerry Cullinan The City of San Francisco has filed a historic lawsuit against 10 ultra-processed food (UPF) manufacturers, seeking “restitution and civil penalties” to help local governments to “offset astronomical health care costs associated with UPF consumption”. The 10 companies are Kraft Heinz Company, Mondelez International, Post Holdings, The Coca-Cola Company, PepsiCo, General Mills, Nestle USA, Kellogg, […] Continue reading -> Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> Paper Exonerating Herbicide is Retracted; Bayer Gets Trump’s Help to Avoid Claims from Cancer Patients 04/12/2025 Kerry Cullinan A scientific paper written 25 years ago, claiming that the herbicide glyphosate posed little risk to people, has finally been withdrawn after it was found that the authors relied solely on Monsanto studies and did not acknowledge that Monsanto staff had assisted in writing the paper. Monsanto makes the glyphosate-based Roundup, used as a weedkiller […] Continue reading -> WHO Issues First-Ever Guidelines for GLP-1 Drugs – Including Obesity 04/12/2025 Sophia Samantaroy First-ever WHO guidelines recommending the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults has been issued by the World Health Organization – in what the global health agency said is a “conditional” sign of approval for the cutting edge medications that have become widely popular. The new WHO recommendations go […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US City Sues Ultra-Processed Food Companies, Seeking ‘Restitution’ for Health Costs 05/12/2025 Kerry Cullinan The City of San Francisco has filed a historic lawsuit against 10 ultra-processed food (UPF) manufacturers, seeking “restitution and civil penalties” to help local governments to “offset astronomical health care costs associated with UPF consumption”. The 10 companies are Kraft Heinz Company, Mondelez International, Post Holdings, The Coca-Cola Company, PepsiCo, General Mills, Nestle USA, Kellogg, […] Continue reading -> Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> Paper Exonerating Herbicide is Retracted; Bayer Gets Trump’s Help to Avoid Claims from Cancer Patients 04/12/2025 Kerry Cullinan A scientific paper written 25 years ago, claiming that the herbicide glyphosate posed little risk to people, has finally been withdrawn after it was found that the authors relied solely on Monsanto studies and did not acknowledge that Monsanto staff had assisted in writing the paper. Monsanto makes the glyphosate-based Roundup, used as a weedkiller […] Continue reading -> WHO Issues First-Ever Guidelines for GLP-1 Drugs – Including Obesity 04/12/2025 Sophia Samantaroy First-ever WHO guidelines recommending the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults has been issued by the World Health Organization – in what the global health agency said is a “conditional” sign of approval for the cutting edge medications that have become widely popular. The new WHO recommendations go […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> Paper Exonerating Herbicide is Retracted; Bayer Gets Trump’s Help to Avoid Claims from Cancer Patients 04/12/2025 Kerry Cullinan A scientific paper written 25 years ago, claiming that the herbicide glyphosate posed little risk to people, has finally been withdrawn after it was found that the authors relied solely on Monsanto studies and did not acknowledge that Monsanto staff had assisted in writing the paper. Monsanto makes the glyphosate-based Roundup, used as a weedkiller […] Continue reading -> WHO Issues First-Ever Guidelines for GLP-1 Drugs – Including Obesity 04/12/2025 Sophia Samantaroy First-ever WHO guidelines recommending the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults has been issued by the World Health Organization – in what the global health agency said is a “conditional” sign of approval for the cutting edge medications that have become widely popular. The new WHO recommendations go […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Paper Exonerating Herbicide is Retracted; Bayer Gets Trump’s Help to Avoid Claims from Cancer Patients 04/12/2025 Kerry Cullinan A scientific paper written 25 years ago, claiming that the herbicide glyphosate posed little risk to people, has finally been withdrawn after it was found that the authors relied solely on Monsanto studies and did not acknowledge that Monsanto staff had assisted in writing the paper. Monsanto makes the glyphosate-based Roundup, used as a weedkiller […] Continue reading -> WHO Issues First-Ever Guidelines for GLP-1 Drugs – Including Obesity 04/12/2025 Sophia Samantaroy First-ever WHO guidelines recommending the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults has been issued by the World Health Organization – in what the global health agency said is a “conditional” sign of approval for the cutting edge medications that have become widely popular. The new WHO recommendations go […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Issues First-Ever Guidelines for GLP-1 Drugs – Including Obesity 04/12/2025 Sophia Samantaroy First-ever WHO guidelines recommending the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults has been issued by the World Health Organization – in what the global health agency said is a “conditional” sign of approval for the cutting edge medications that have become widely popular. The new WHO recommendations go […] Continue reading -> Posts navigation Older posts